Merck | MRK - Market Capitalization


Merck reported $376.1B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 521.8B 77.2B Oct/2026
Abbott USD 181.89B 10.88B Oct/2026
ALKERMES USD 8.73B 2.85B Jun/2026
Amgen USD 195.44B 5.55B Jun/2026
AstraZeneca USD 215.06B 74.93B Oct/2026
Biogen USD 35.56B 2.19B Oct/2026
Bristol-Myers Squibb USD 124.51B 2.96B Oct/2026
Coherus Biosciences USD 172M 19M Dec/2025
Drreddys Laboratories INR 11.07B 619M Mar/2026
Eli Lilly USD 1.31T 216.84B Oct/2026
Gilead Sciences USD 206.51B 21.7B Oct/2026
GlaxoSmithKline GBP 74.9B 785.69M Oct/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
J&J USD 607B 46.61B Oct/2026
Medtronic USD 109.3B 2.33B Jun/2026
Merck USD 370.6B 12.1B Oct/2026
Novartis USD 266.01B 25.42B Oct/2026
Novartis USD 288.26B 25.18B Mar/2026
Novo Nordisk A/S DKK 1.4T 373.76B Jun/2026
Pacira USD 1.69B 695M Oct/2026
Pfizer USD 138.44B 15.37B Jun/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.24B 566M Jun/2026
Regeneron Pharmaceuticals USD 100.79B 35.42B Oct/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 99.83B 8.68B Oct/2026
Sanofi EUR 113.52B 3.82B Mar/2026
United Therapeutics USD 23B 2.19B Jun/2026
Zoetis USD 30.13B 19.58B Jun/2026